Načítá se...
The use of β(2)-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines
Despite scientific evidence proving that inhaled β(2)-adrenergic receptor (β(2)-AR) agonists can reverse bronchoconstriction in all ages, current guidelines advocate against the use of β(2)-AR bronchodilators in infants with viral bronchiolitis because clinical trials have not demonstrated an overal...
Uloženo v:
| Vydáno v: | ERJ Open Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7553108/ https://ncbi.nlm.nih.gov/pubmed/33083437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00135-2020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|